Gastric and Soft Tissue Neoplasms 2026

Saturday, November 7, 2026, 7:30 AM - 3:10 PM, Hoya Hotel, Washington, DC


This annual educational symposium is proud to update our medical community on the state-of-the-art care of gastric cancer, gastrointestinal stromal tumors, and retroperitoneal sarcomas while focusing on the importance of a multidisciplinary approach to the diagnosis and treatment of these complex disease entities. National renowned guest speakers and distinguished faculty, including those from MedStar Health and MedStar Georgetown Cancer Institute, will discuss the significant roles of endoscopic procedures, evolving new diagnostic modalities, hereditary genetic testing, precision medicine, immune, regional, and molecular targeted therapies, and evolving biomarkers in these cancers. This symposium will also highlight evolving role of peritoneal based therapies for advanced gastric cancer.

1. Identify the diagnostic and therapeutic role of endoscopy in gastric cancer.
2. Recognize the current standard of care and evolving approaches incorporating chemotherapy, immunotherapy, targeted therapy, surgery, and radiation in peri-operative management of gastric cancer, including unique approaches in mismatch repair deficient subtypes.
3. Recognize the importance of tissue molecular markers and circulating tumor DNA in the diagnosis and treatment of advanced gastric cancer.
4. Understand the evolving role of cytoreductive surgeries and intra-peritoneal therapies in the management of advanced gastric cancer with metastatic peritoneal disease.
5. Identify hereditary syndromes and high-risk populations linked to gastric cancer and recognize evolving screening approaches
6. Discuss the role of surgery in treating gastrointestinal stromal tumors and retroperitoneal sarcomas
7. Discuss the roles of systemic and targeted therapies in gastrointestinal stromal tumors and retroperitoneal sarcomas.
8. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with gastric cancer, gastrointestinal stromal tumors, and retroperitoneal sarcomas.

Early Bird Now to August 31

• Physician                                                 $125

• Resident or Fellow                                 $0

• Physician Assistant                                $100

• Nurse Practitioner                                 $100

• Nurse                                                       $100

• Allied Health Professional                    $100

• Industry Professional                            $225

Regular September 1 to Onsite

• Physician                                                  $150

• Resident or Fellow                                  $0

• Physician Assistant                                 $125

• Nurse Practitioner                                  $125

• Nurse                                                        $125

• Allied Health Professional                     $125

• Industry Professional                             $250

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  



Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 4.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

 

Physicians: MedStar Health designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine MOC Credit:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Surgery CC Credit:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

 

MOC/CC Participation Threshold: Learner participates by writing a reflective statement and makes a commitment to change or maintain an element of practice.

 

Nurses: This activity is approved for 4.25 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants: 

MedStar Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

AMA PRA Category 1 Credits™ Physician (4.50 hours), Interprofessional Continuing Education (4.50 hours), Non-Physician Member of the Healthcare Team (4.50 hours), Nurse - ANCC (4.50 hours)

The Hoya Hotel at Georgetown

3800 Reservoir Road, NW

Washington, DC 20007

Saturday, November 7, 2026

Please contact Ada Guo at [email protected] for information on exhibiting at this conference.